Page last updated: 2024-12-06
barium nitrate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
barium nitrate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
barium nitrate : An inorganic nitrate salt of barium. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 24798 |
CHEMBL ID | 3184584 |
CHEBI ID | 190440 |
MeSH ID | M0080910 |
Synonyms (45)
Synonym |
---|
AKOS015833342 |
barium nitrate (ba(no3)2) |
einecs 233-020-5 |
ccris 4140 |
barium dinitrate |
nitric acid, barium salt |
nitrobarite |
nitrate de baryum [french] |
un1446 |
barium(ii) nitrate (1:2) |
dusicnan barnaty [czech] |
barium nitrate |
hsdb 401 |
nitrato barico [spanish] |
nitric acid barium salt (2:1) |
nitrate de baryum |
barium(ii) nitrate |
10022-31-8 |
nitric acid barium salt |
CHEBI:190440 , |
nitric acid, barium salt (2:1) |
nitrato barico |
mdc5sw56xc , |
ec 233-020-5 |
dusicnan barnaty |
unii-mdc5sw56xc |
barium nitrate [un1446] [oxidizer] |
cas-10022-31-8 |
dtxsid8049200 , |
dtxcid3028471 |
NCGC00260262-01 |
tox21_202714 |
FT-0622572 |
barium nitrate [hsdb] |
barium nitrate [mi] |
IWOUKMZUPDVPGQ-UHFFFAOYSA-N |
CHEMBL3184584 |
mfcd00003442 |
BCP25811 |
Q407666 |
ba (n o3)2 |
barium nitrate, acs grade |
bariumnitrat |
barium dinitrat |
barytsalpeter |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (2)
Class | Description |
---|---|
inorganic barium salt | |
inorganic nitrate salt | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (1)
Potency Measurements
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 2.9822 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (18.75) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 79.88
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (79.88) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (5.88%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 4 (23.53%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (70.59%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |